Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Vibalogics
Sort By
Newest First
1 / 1
CDMO Acquisition
Vibalogics Acquired by Top Global CDMO Recipharm AB
Vibalogics
PR-M02-22-18
Feb 18, 2022
Oncolytic Virus
Specialized Know-How and Capacity to Support Demand for Oncolytic Viruses
Kai Lipinski, Ph.D.; Stefan Beyer, Ph.D.
Vibalogics
PAP-Q1-20-CL-032
Mar 19, 2020
1 / 1
